Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
Teva
Farmers Insurance
Moodys
US Department of Justice
UBS
Express Scripts
Mallinckrodt

Generated: April 25, 2018

DrugPatentWatch Database Preview

Trioxsalen - Generic Drug Details

« Back to Dashboard

What are the generic sources for trioxsalen and what is the scope of trioxsalen patent protection?

Trioxsalen
is the generic ingredient in one branded drug marketed by Valeant Pharm Intl and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for trioxsalen.
Summary for trioxsalen
Medical Subject Heading (MeSH) Categories for trioxsalen
Synonyms for trioxsalen
2,5,9-trimethyl-7-furo[3,2-g][1]benzopyranone
2,5,9-Trimethyl-7H-furo(3,2-g)(1)benzopyran-7-one
2,5,9-Trimethyl-7H-furo[3,2-g]chromen-7-one
2,5,9-Trimethyl-7H-furo[3,2-g]chromen-7-one #
2,5,9-Trimethylfuro[3,2-g]benzopyran-7-one
2,5,9-trimethylfuro[3,2-g]chromen-7-one
2,5,9-Trimethylpsoralen
2,9-Trimethyl-7H-furo[3,2-g][1]benzopyran-7-one
2',4,8-Trimethylpsoralen
2',8-Trimethylpsoralen
3902-71-4
4,5,8-Trimethylpsoralen
4,5',8-Trimethylpsoralen
4,5',8-Trimethylpsoralene
4,7,9-trimethyl-2H-furo[3,2-g]chromen-2-one
4,7,9-trimethylfurano[3,2-g]chromen-2-one
4,8-Trimethylpsoralen
4,8-Trimethylpsoralene
4,8,5'-Trimethylpsoralen
5-19-04-00472 (Beilstein Handbook Reference)
5-Benzofuranacrylic acid, 6-hydroxy-.beta.,2,7-trimethyl-, .delta.-lactone
5-Benzofuranacrylic acid,2,7-trimethyl-, .delta.-lactone
6-Hydroxy-beta,2,7-trimethyl-5-benzofuranacrylic acid gamma-lactone
6-hydroxy-beta,2,7-trimethyl-5-benzofuranacrylic acid, delta-lactone
7-Oxo-2,5,9-Trimethyl-7H-furo(3,2-g)(1)benzopyron
7H-Furo(3,2-g)(1)benzopyran-7-one, 2,5,9-trimethyl-
7H-Furo[3, 2,5,9-trimethyl-
7H-Furo[3,2-g][1]benzopyran-7-one, 2,5,9-trimethyl-
902T714
A-8462
A824380
AB00052119_09
AB2000428
AC1L1KOB
ACM3902714
ACon0_000603
ACon1_000251
AKOS015912601
antipsoriatic
ANW-41902
BENZOFURANACRYLIC ACID,2,7-TRIMETHYL-,
Bio-0865
BPBio1_000987
BRD-K54790157-001-06-4
BRN 0221723
BSPBio_000897
BSPBio_002936
C-13067
C09314
CAS-3902-71-4
CC-35440
CCG-39937
CHEBI:28329
CHEMBL1475
CS-4760
D01034
D0FA2O
DB04571
DivK1c_000380
DR000470
DSSTox_CID_3716
DSSTox_GSID_23716
DSSTox_RID_77160
DTXSID3023716
EINECS 223-459-0
Elder 8011
EN300-122631
FMHHVULEAZTJMA-UHFFFAOYSA-N
FT-0603651
HMS1570M19
HMS1921I05
HMS2092A12
HMS2097M19
HMS2879M06
HMS501C22
HY-B1157
I14-48205
IDI1_000380
J10195
KBio1_000380
KBio2_000649
KBio2_003217
KBio2_005785
KBio3_002156
KBioGR_001286
KBioSS_000649
KS-5184
LACTONE
LS-70743
MCULE-5301264270
MEGxm0_000462
MFCD00005010
MLS001173417
MolPort-001-740-054
NCGC00016643-01
NCGC00016643-02
NCGC00016643-03
NCGC00016643-04
NCGC00016643-05
NCGC00016643-06
NCGC00016643-09
NCGC00016643-10
NCGC00094804-01
NCGC00094804-02
NCGC00178384-01
NCGC00178384-02
NCGC00178384-03
NCI60_038883
NINDS_000380
NSC 71047
NSC-71047
NSC-757371
NSC71047
NSC757371
Oprea1_203343
Pharmakon1600-01500596
PL022692
Prestwick_148
Prestwick0_000709
Prestwick1_000709
Prestwick2_000709
Prestwick3_000709
SBI-0051547.P002
SCHEMBL1252
SDCCGMLS-0066609.P001
SMR000538905
SPBio_001126
SPBio_002818
Spectrum_000169
SPECTRUM1500596
Spectrum2_001083
Spectrum3_001378
Spectrum4_000883
Spectrum5_001557
SR-01000812969
SR-01000812969-2
ST083486
Tox21_110541
Tox21_110541_1
TR-015676
Trimethylpsoralen
Trimethylpsoralen;Trioxysalen;Trisoralen;Trisoralen
Trioxalen
Trioxisaleno
Trioxisaleno [INN-Spanish]
Trioxsalen (USP)
Trioxsalen [USAN:USP]
Trioxsalen [USAN]
Trioxsalen, >=98% (HPLC), powder
Trioxsalen, United States Pharmacopeia (USP) Reference Standard
TRIOXSALIN
Trioxysalen
Trioxysalen (JAN/INN)
Trioxysalene
Trioxysalene [INN-French]
Trioxysalenum
Trioxysalenum [INN-Latin]
Trisoralen
Trisoralen (TN)
Trixsalen
UNII-Y6UY8OV51T
W0082
Y6UY8OV51T
Z1551429738
ZB000511
ZINC2226

US Patents and Regulatory Information for trioxsalen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl TRISORALEN trioxsalen TABLET;ORAL 012697-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Johnson and Johnson
Farmers Insurance
Fish and Richardson
UBS
Covington
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.